Risk factors of septic shock development and thirty-day mortality with a predictive model in adult candidemia patients in intensive care units

References

• Bitar D, Lortholary O, Strat YL, et al. Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis. 2014;20(7):1149–1155.
   PubMed Web of Science ®Google Scholar
• Suleyman G, Alangaden GJ. Nosocomial fungal infections: epidemiology, infection control, and prevention. Infect Dis Clin North Am. 2016;30(4):1023–1052.
   PubMed Web of Science ®Google Scholar
• Rosenthal VD, Gupta D, Rajhans P, et al. Six-year multicenter study on short-term peripheral venous catheters-related bloodstream infection rates in 204 intensive care units of 57 hospitals in 19 cities of India: International Nosocomial Infection Control Consortium (INICC) findings. Am J Infect Control. 2020;48(9):1001–1008.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Ebbers J, Geurtz L, et al. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents. 2014;43(1):78–81.
   PubMed Web of Science ®Google Scholar
• Kang SJ, Kim SE, Kim UJ, et al. Clinical characteristics and risk factors for mortality in adult patients with persistent candidemia. J Infect. 2017;75(3):246–253.
   PubMed Web of Science ®Google Scholar
• Luhr R, Cao Y, Söderquist B, et al. Trends in sepsis mortality over time in randomised sepsis trials: a systematic literature review and meta-analysis of mortality in the control arm, 2002–2016. Crit Care. 2019;23(1):241–249.
   PubMedGoogle Scholar
• Dugar S, Choudhary C, Duggal A. Sepsis and septic shock: guideline-based management. Cleve Clin J Med. 2020;87(1):53–64.
   PubMed Web of Science ®Google Scholar
• Minasyan H. Sepsis and septic shock: pathogenesis and treatment perspectives. J Crit Care. 2017;40:229–242.
   PubMed Web of Science ®Google Scholar
• Walkey AJ, Wiener RS, Lindenauer PK. Utilization patterns and outcomes associated with central venous catheter in septic shock: a population-based study. Crit Care Med. 2013;41(6):1450–1457.
   PubMed Web of Science ®Google Scholar
• Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. J Am Med Assoc. 2014;311(13):1308–1316.
   PubMed Web of Science ®Google Scholar
• Hadley S, Lee WW, Ruthazer R, et al. Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients. Crit Care Med. 2002;30(8):1808–1814.
   PubMed Web of Science ®Google Scholar
• Guzman JA, Tchokonte R, Sobelc JD. Septic shock due to candidemia: outcomes and predictors of shock development. J Clin Med Res. 2011;3:65–71.
   PubMedGoogle Scholar
• Bassetti M, Vena A, Meroi M, et al. Factors associated with the development of septic shock in patients with candidemia : a post hoc analysis from two prospective cohorts. Crit Care. 2020;24(1):117.
   PubMed Web of Science ®Google Scholar
• Jung IY, Jeong SJ, Kim YK, et al. A multicenter retrospective analysis of the antifungal susceptibility patterns of Candida species and the predictive factors of mortality in South Korean patients with candidemia. Medicine. 2020;99(11):e19494.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis. 2006;25(7):419–425.
   PubMed Web of Science ®Google Scholar
• Wang TY, Hung CY, Shie S, et al. The clinical outcomes and predictive factors for in-hospital mortality in non-neutropenic patients with candidemia. Med. 2016;95:1–5.
   Web of Science ®Google Scholar
• Keighley C, Chen SCA, Marriott D, et al. Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study. BMC Infect Dis. 2019;19(1):445.
   PubMedGoogle Scholar
• Gaspar GG, Menegueti MG, Auxiliadora-Martins M, et al. Evaluation of the predictive indices for candidemia in an adult intensive care unit. Rev Soc Bras Med Trop. 2015;48(1):77–82.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour C, Shankar-Hari M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). J Am Med Assoc. 2016;315(8):801–810.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–50.
   PubMed Web of Science ®Google Scholar
• Vergidis P, Clancy CJ, Shields RK, et al. Intra-abdominal candidiasis: the importance of early source control and antifungal treatment. PLoS One. 2016;11(4):e0153247–13.
   PubMed Web of Science ®Google Scholar
• Segal BH, Herbrecht R, Stevens DA, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria. Clin Infect Dis. 2008;47(5):674–683.
   PubMed Web of Science ®Google Scholar
• Poissy J, Damonti L, Bignon A, et al. Risk factors for candidemia: a prospective matched case-control study. Crit Care. 2020;24(1):109.
   PubMed Web of Science ®Google Scholar
• Patel GP, Simon D, Scheetz M, et al. The effect of time to antifungal therapy on mortality in candidemia associated septic shock. Am J Ther. 2009;16(6):508–511.
   PubMed Web of Science ®Google Scholar
• Sbrana F, Sozio E, Bassetti M, et al. Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards. Intern Emerg Med. 2018;13(2):199–204.
   PubMed Web of Science ®Google Scholar
• Whiles BB, Deis AS, Simpson SQ. Increased time to initial antimicrobial administration is associated with progression to septic shock in severe sepsis patients. Crit Care Med. 2017;45(4):623–629.
   PubMed Web of Science ®Google Scholar
• Hesstvedt L, Gaustad P, Müller F, et al. The impact of age on risk assessment, therapeutic practice and outcome in candidemia. Infect Dis. 2019;51(6):425–434.
   PubMed Web of Science ®Google Scholar
• Yan J, Li S, Li S. The role of the liver in sepsis. Int Rev Immunol. 2014;33(6):498–510.
   PubMed Web of Science ®Google Scholar
• Cornely FB, Cornely OA, Salmanton‐García J, et al. Attributable mortality of candidemia after introduction of echinocandins. Mycoses. 2020;63(12):1373–1381. Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Cuervo G, Garcia-Vidal C, Puig-Asensio M, et al. Usefulness of guideline recommendations for prognosis in patients with candidemia. Med Mycol. 2019;57(6):659–667.
   PubMed Web of Science ®Google Scholar
• Puig-Asensio M, Padilla B, Garnacho-Montero J, et al. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect. 2014;20(4):O245–O254.
   PubMed Web of Science ®Google Scholar
• Chen PY, Chuang YC, Wang JT, Sheng WH, et al. Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010. J Microbiol Immunol Infect. 2014;47(2):95–103.
   PubMedGoogle Scholar
• Ng K, Schorr C, Reboli AC, et al. Incidence and mortality of sepsis, severe sepsis, and septic shock in intensive care unit patients with candidemia. Infect Dis. 2015;47(8):584–587.
   PubMed Web of Science ®Google Scholar
• Lortholary O, Renaudat C, Sitbon K, et al. The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med. 2017;43(5):652–662.
   PubMed Web of Science ®Google Scholar
• Jutiamornlerd N, Chusri S, Sirsipaitoon P. Epidemiology of candidemia in Songklanagarind hospital. J Med Assoc Thail. 2011;94:927–932.
   PubMedGoogle Scholar
• Chen LY, Liao SY, Kuo SC, et al. Changes in the incidence of candidaemia during 2000–2008 in a tertiary medical centre in northern Taiwan. J Hosp Infect. 2011;78(1):50–53.
   PubMed Web of Science ®Google Scholar
• Fortún J, Martín-Dávila P, Gómez-García de la Pedrosa E, et al. Emerging trends in candidemia: a higher incidence but a similar outcome. J Infect. 2012;65(1):64–70.
   PubMed Web of Science ®Google Scholar
• Ishikane M, Hayakawa K, Kutsuna S, et al. The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years. PLoS One. 2019;14(4):e0215996–15.
   PubMed Web of Science ®Google Scholar
• Kim SH, Yoon YK, Kim MJ, et al. Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia. J Antimicrob Chemother. 2013;68(12):2890–2897.
   PubMed Web of Science ®Google Scholar
• Kim JU, Kim M, Kim S, et al. Dendritic cell dysfunction in patients with end-stage renal disease. Immune Netw. 2017;17(3):152–162.
   PubMed Web of Science ®Google Scholar
• Yeoh SF, Lee TJ, Chew KL, et al. Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation. Infect Drug Resist. 2018;11:805–819.
   PubMed Web of Science ®Google Scholar
• Alves J, Palma P, Azevedo D, et al. Candidemia in the patient with malignancy. Hosp Pract. 2018;46(5):246–252.
   Google Scholar
• Schroeder M, Weber T, Denker T, et al. Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: a single-center retrospective 10-year analysis. Ann Intensive Care. 2020;10(1):142.
   PubMed Web of Science ®Google Scholar
• Chow JK, Golan Y, Ruthazer R, et al. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med. 2008;36(7):1993–1998.
   PubMed Web of Science ®Google Scholar
• Ortíz Ruiz G, Osorio J, Valderrama S, et al. Risk factors for candidemia in non-neutropenic critical patients in Colombia. Med Intensiva. 2016;40(3):139–144.
   PubMed Web of Science ®Google Scholar
• Nucci M, Braga PR, Nouér SA, et al. Time of catheter removal in candidemia and mortality. Braz J Infect Dis. 2018;22(6):455–461.
   PubMed Web of Science ®Google Scholar
• Lee YM, Kim DY, Kim YJ, et al. Clinical impacts of delayed central venous catheter removal according to the severity of comorbidities in patients with candidaemia. J Hosp Infect. 2019;103(4):420–427.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Righi E, Ansaldi F, et al. A multicenter study of septic shock due to candidemia: Outcomes and predictors of mortality. Intensive Care Med. 2014;40(6):839–845.
   PubMed Web of Science ®Google Scholar
• Kuse ER, Chetchotisakd P, da Cunha CA, et al. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet. 2007;369(9572):1519–1527.
   PubMed Web of Science ®Google Scholar
• Nemer S, Imtiaz T, Varikkara M, et al. Management of candidaemia with reference to the European confederation of medical mycology quality indicators. Infect Dis. 2019;51(7):527–533.
   PubMed Web of Science ®Google Scholar
• Choi H, Kim JH, Seong H, et al. Changes in the utilization patterns of antifungal agents, medical cost and clinical outcomes of candidemia from the health-care benefit expansion to include newer antifungal agents. Int J Infect Dis. 2019;83:49–55.
   PubMed Web of Science ®Google Scholar
• López-Cortés LE, Almirante B, Cuenca-Estrella M, et al. Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort. Clin Microbiol Infect. 2016;22(8):733.e1–e8.
   Web of Science ®Google Scholar
• Andes DR, Safdar N, Baddley JW, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54(8):1110–1122.
   PubMed Web of Science ®Google Scholar